In order to improve the diagnosis and treatment ability of prostate cancer and endocrine metabolic diseases, promote multidisciplinary collaboration and integration of medical practice, and actively respond to the challenge of comorbidity, the "multidisciplinary new progress and Innovation Series exchange meeting - prostate cancer endocrine diagnosis and Treatment Seminar (Phase V)" hosted by Chengdu high tech medical association was successfully held on February 9, 2026.

The meeting focused on the frontier of endocrine diagnosis and treatment of prostate cancer, and carried out in-depth discussion around the multidisciplinary collaboration (MDT) diagnosis and treatment mode. A number of well-known domestic experts were invited to participate in the meeting, sharing the latest academic achievements and clinical practice experience through special lectures, case discussions and other forms, and building a high-level communication platform for clinical workers.

This meeting strengthened interdisciplinary exchanges and cooperation, helped the standardized and accurate development of endocrine diagnosis and treatment of prostate cancer, and was of positive significance to improving the comprehensive diagnosis and treatment level of regional urinary tumors and endocrine diseases and serving the health of patients.